0000899243-22-015908.txt : 20220428
0000899243-22-015908.hdr.sgml : 20220428
20220428205949
ACCESSION NUMBER: 0000899243-22-015908
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220413
FILED AS OF DATE: 20220428
DATE AS OF CHANGE: 20220428
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brigido Stephen
CENTRAL INDEX KEY: 0001869791
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38914
FILM NUMBER: 22869535
MAIL ADDRESS:
STREET 1: C/O CELULARITY INC.
STREET 2: 170 PARK AVENUE
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celularity Inc
CENTRAL INDEX KEY: 0001752828
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831702591
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 170 PARK AVE
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
BUSINESS PHONE: 609-235-1010
MAIL ADDRESS:
STREET 1: 170 PARK AVE
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
FORMER COMPANY:
FORMER CONFORMED NAME: GX Acquisition Corp.
DATE OF NAME CHANGE: 20180912
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-04-13
0
0001752828
Celularity Inc
CELU
0001869791
Brigido Stephen
C/O CELULARITY INC.
170 PARK AVENUE
FLORHAM PARK
NJ
07932
0
1
0
0
Pres, Functional Regeneration
Class A Common Stock
2022-04-13
4
A
0
32809
A
32809
D
Stock Option (Right to Buy)
10.16
2022-04-13
4
A
0
96201
0.00
A
2032-04-13
Class A Common Stock
96201
96201
D
These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock. The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.
This option shall vest and become exercisable over a four-year period, with 25% of the option vesting on the one-year anniversary of the grant date, and the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.
/s/ Keary Dunn, Attorney-in-Fact
2022-04-28